Kosaka et al. (2013) showed that inactivation of neutral sphingomyelinase 2 (nSMase2), which is a protein involved in lEV release, led to a reduction in miRNA secretion in EVs and inhibited lung metastasis of breast cancer in a mouse model [51]. Here, SMPD3 is linked to breast cancer.